Somatostatin is a specific inhibitor of SDF-1α-induced T cell infiltration

Clinical and Experimental Immunology

Volumn 135, Issue 3, 2004, Pages 434-439

  Talme, T ^a   Ivanoff, J ^b   Sundqvist, K G ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Extracellular matrix; Neuropeptides; SDF 1 ; Somatostatin; T cell infiltration

Indexed keywords

BETA ENDORPHIN; CYCLOSOMATOSTATIN; METENKEPHALIN; NEUROPEPTIDE; NEUROPEPTIDE Y; OPIATE DERIVATIVE; PROTEIN INHIBITOR; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR; STROMAL CELL DERIVED FACTOR 1; SUBSTANCE P; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL ADHESION; DRUG MECHANISM; DRUG SPECIFICITY; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD29; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; NEUROPEPTIDES; RECEPTORS, CHEMOKINE; SOMATOSTATIN; T-LYMPHOCYTE SUBSETS;

EID: 1542329258     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02370.x     Document Type: Article

References (32)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14.
2. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272:60-6.
3. Wilkinson PC, Lackie JM, Forrester J et al. Chemokinetic accumulation of human neutrophils on immune complex-coated substrata: analysis at a boundary. J Cell Biol 1984; 99:1761-8.
4. Schor SL, Allen TD, Winn B. Lymphocyte migration into three-dimensional collagen matrices: a quantitative study. J Cell Biol 1983; 96:1089-96.
5. Sundqvist KG, Hauzenberger D, Hultenby K et al. T lymphocyte infiltration of two-and three-dimensional collagen substrata by an adhesive mechanism. Exp Cell Res 1993; 206:100-10.
6. Ivanoff A, Ivanoff J, Hultenby K et al. Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1). Clin Exp Metastasis 1999; 17:695-711.
7. Ivanoff J, Ivanoff A, Sundqvist KG. Defective chemokine production in T leukemia cell lines and its possible functional role. Dev Immunol 2000; 7:67-75.
8. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. New Engl J Med 1998; 338:436-45.
9. Cantrell D. G proteins in lymphocyte signalling. Curr Opin Immunol 1994; 6:380-4.
10. Böhm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. J Biochem 1997; 322:1-18.
11. Hall AG. Proteins and small GTPases: distant relatives keep in touch. Science 1998; 280:2074-5.
12. Sanchez-Madrid F, del Pozo MA. Leukocyte polarization in cell migration and immune interactions. EMBO J 1999; 18:501-11.
13. Voermans C, Anthony EC, Mul E et al. SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells. Exp Hematol 2001; 29:1456-64.
14. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:565-8.
15. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129-34.
16. Farber JM. Mig and IP-10: CXC chemokines that targets lymphocytes. J Leukoc Biol 1997; 61:246-57.
17. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 2000; 177:175-84.
18. Reubi JC, Horisberger U, Kappeler A et al. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood 1998; 92:191-7.
19. Van Hagen PM. Somatostatin receptor expression in clinical immunology. Metabolism 1996; 45:86-7.
20. Stevens-Felten SY, Bellinger DL. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 1997; 69:99-131.
21. Talme T, Ivanoff J, Hägglund M et al. Somatostatin receptor (SSTR) expression and function in normal and leukemic T cells. Evidence for selective effects on adhesion to extra-cellular matrix components via SSTR2 and/or 3. Clin Exp Immunol 2001; 123:1-10.
22. Tsutsumi A, Takano H, Ichikawa K et al. Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells. Cell Immunol 1997; 181:44-9.
23. Reichlin S. Somatostatin. N Engl J Med 1983; 309:1556-63.
24. Payan DG, Hess CA, Goetzl EJ. Inhibition by somatostatin of the proliferation of T lymphocytes and molt-4 lymphoblasts. Cell Immunol 1984; 84:433-8.
25. Patel YC. General aspects of the biology and function of somatostatin. In: Weil C, Muller EE, Thorner MO, eds. Basic and clinical aspects of neuroscience, vol. 4. Berlin: Springer-Verlag, 1992:1-16.
26. Lamberts SW, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12:450-82.
27. Pollak MN, Scally AV. Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 1998; 217:143-52.
28. Xia M, Leppert D, Hauser SL et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996; 156:160-7.
29. Johnatty RN, Taub DD, Reeder SP et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997; 158:2327-33.
30. Wolf K, Mueller R, Borgmann S, Broecker EB, Friedl P. Amoeboid shape change and contact guidance. T lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003; 102:3262-9.
31. Szabo I, Chen XH, Xin L et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 2002; 99:10276-81.
32. Soriano SF, Hernanz-Falcon P, Rodriguez-Frade JM et al. Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J Exp Med 2002; 196:311-21.